Semi-Annual Consolidated Statement Of Cash Flows

Immuno-Biological Laboratories Co., Ltd. - Filing #7545794

Concept 2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
12,747,000 JPY
-56,644,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.